A mixture of SERS nanotags conjugated to specific antibodies (Rh6G-EGFR, MGITC-CD44, and Cy5-TGFβRII) were injected intratumorally to detect breast cancer cells under both in vitro and in vivo conditions. Here, CD44 is linked to breast carcinoma.